TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Enzyme Processing where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Enzyme Processing technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Enzyme Processing

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Enzyme Processing industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Enzyme Processing industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Enzyme Processing industry

Downy Mildew Resistance Providing Genes In SunflowerENZA ZADEN BEHEERJul 16, 2025SOLTIS LIMAGRAIN EUROPE LIDEA FRANCE
Process For Enzymatic Oil DegummingDSM ASSETSJul 8, 2025CABINET BECKER ET ASSOCIES
Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence ManipulationMASSACHUSETTS INSTITUTE OF TECHNOLOGYMar 19, 2025VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic ApplicationsTHE BROAD INSTITUTEMar 12, 2025VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionUNIQURE BIOPHARMAJan 31, 2025PFIZER
Guide Rna With Chemical ModificationsAGILENTJan 24, 2025KRAUS & LEDERER PARTGMBB
Guide Rna With Chemical ModificationsAGILENTJan 22, 2025DORRIES
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 15, 2025DORRIES
Guide Rna With Chemical ModificationsAGILENTJan 14, 2025WUESTHOFF & WUESTHOFF
Hyperactive Piggybac TransposasesPOSEIDA THERAPEUTICSJan 2, 2025HGF

To stay ahead in the competitive Enzyme Processing industry, companies are constantly innovating. Here are the top patents facing oppositions in the Enzyme Processing industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Sep 20, 2017Crispr-Based Genome Modification And RegulationSIGMA ALDRICH10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICS10
Dec 5, 2018Crispr-Based Genome Modification And RegulationSIGMA ALDRICH9
Oct 2, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH8
Oct 9, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH8
Nov 27, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH7
Dec 5, 2018Crispr-Based Genome Modification And RegulationSIGMA ALDRICH6
Aug 22, 2018Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use ThereofTOOLGEN INCORPORATED6
Oct 12, 2022Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing ImmunoglobulinsUNIVERSIT PARIS CIT6
Jun 13, 2018Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionUNIQURE BIOPHARMA5